Cardiopulmonary hemodynamic responses to the small injection of hemoglobin vesicles (artificial oxygen carriers) in miniature pigs

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 10, 2012, Pages 2668-2677

  Sakai, Hiromi ^a,b   Suzuki, Yuji ^c   Sou, Keitaro ^a   Kano, Mayumi ^c  

^a WASEDA UNIVERSITY   (Japan)

^b Waseda University   (Singapore)

^c Nihon Bioresearch Inc   (Japan)

Author keywords

blood substitutes; liposome; pulmonary hypertension; pulmonary intravascular macrophages; thromboxane

Indexed keywords

ARTERIAL PRESSURES; ARTIFICIAL OXYGEN CARRIER; CARDIAC OUTPUT; CIRCULATORY DISORDERS; ELECTRON MICROGRAPH; HEART RATES; HEMODYNAMIC RESPONSE; HEMOGLOBIN VESICLES; INTRAVASCULAR; INTRAVENOUS INJECTIONS; LIPID COMPOSITION; PHOSPHATIDYLGLYCEROLS; PULMONARY HYPERTENSION; TEST FLUIDS; THROMBOCYTOPENIA; THROMBOXANE;

ANTIGEN-ANTIBODY REACTIONS; BLOOD PRESSURE; BLOOD SUBSTITUTES; HEMOGLOBIN; LIPOSOMES; MACROPHAGES; OXYGEN;

MAMMALS;

1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHATIDYLCHOLINE; 1,2 DISTEAROYL SN GLYCEROL 3 PHOSPHATIDYLETHANOLAMINE N POLYETHYLENE GLYCOL 5000; 1,5 O DIHEXADECYL N SUCCINYL LEVO GLUTAMATE; CARBON MONOXIDE; CHOLESTEROL; COMPLEMENT; GLUTAMIC ACID DERIVATIVE; HEMOGLOBIN; LIPID; LIPOSOME; OXYGEN; PHOSPHATIDYLGLYCEROL; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HEART OUTPUT; HEART RATE; HEMOGLOBIN VESICLE; HUMAN; LEUKOPENIA; LIPID COMPOSITION; LUNG ALVEOLUS MACROPHAGE; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MINIPIG; NONHUMAN; OXYGEN DELIVERY DEVICE; PHAGOCYTOSIS; PULMONARY HYPERTENSION; SYSTEMIC VASCULAR RESISTANCE; THROMBOCYTOPENIA;

ANIMALS; ELECTROCARDIOGRAPHY; HEART; HEMODYNAMICS; HEMOGLOBINS; HUMANS; INJECTIONS; LEUKOCYTE COUNT; LIPOSOMES; LUNG; MALE; OXYGEN; PLATELET COUNT; SUSPENSIONS; SWINE; SWINE, MINIATURE; THROMBOXANE B2; VASCULAR RESISTANCE;

EID: 84865661664     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34208     Document Type: Article

References (44)

1. Torchilin VP,BS,. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005; 4: 145-160. (Pubitemid 40282557)
2. Laing RB, Milne LJ, Leen CL, Malcolm GP, Steers AJ,. Anaphylactic reactions to liposomal amphotericin. Lancet 1994; 344: 682.
3. Schneider P, Klein RM, Dietze L, Söhngen D, Leschke M, Heyll A,. Anaphylactic reaction to liposomal amphotericin (AmBisome). Br J Haematol 1998; 102: 1108-1109. (Pubitemid 28410547)
4. Szebeni J,. Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity. Toxicology 2005; 216: 106-121. (Pubitemid 41712000)
5. Szebeni J, Fontana JL, Wassef NM, Mongan PD, Morse DS, Dobbins DE, Stahl GL, Bünger R, Alving CR,. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: A model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation 1999; 99: 2302-2309. (Pubitemid 29201138)
6. Sakai H, Sou K, Tsuchida E,. Hemoglobin-vesicles as an artificial oxygen carrier. Methods Enzymol 2009; 465: 363-384.
7. Sakai H, Masada Y, Horinouchi H, Yamamoto M, Ikeda E, Takeoka S, Kobayashi K, Tsuchida E,. Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit Care Med 2004; 32: 539-545. (Pubitemid 38234138)
8. Taguchi K, Maruyama T, Iwao Y, Sakai H, Kobayashi K, Horinouchi H, Tsuchida E, Kai T, Otagiri M,. Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model. J Control Release 2009; 136: 232-239.
9. Yamazaki M, Aeba R, Yozu R, Kobayashi K,. Use of hemoglobin vesicles during cardiopulmonary bypass priming prevents neurocognitive decline in rats. Circulation 2006; 114: I220-I225. (Pubitemid 44297154)
10. Cabrales P, Sakai H, Tsai AG, Takeoka S, Tsuchida E, Intaglietta M,. Oxygen transport by low and normal oxygen affinity hemoglobin vesicles in extreme hemodilution. Am J Physiol Heart Circ Physiol 2005; 288: H1885-H1892. (Pubitemid 40418017)
11. Plock JA, Rafatmehr N, Sinovcic D, Schnider J, Sakai H, Tsuchida E, Banic A, Erni D,. Hemoglobin vesicles improve wound healing and tissue survival in critically ischemic skin in mice. Am J Physiol Heart Circ Physiol 2009; 297: H905-H910.
12. 50 Hb vesicles in transiently occluded arterioles of the hamster window model. Am J Physiol Heart Circ Physiol 2005; 288: H2897-H2903. (Pubitemid 40720672)
13. Yamamoto M, Izumi Y, Horinouchi H, Teramura Y, Sakai H, Kohno M, Watanabe M, Kawamura M, Adachi T, Ikeda E, Takeoka S, Tsuchida E, Kobayashi K,. Systemic administration of hemoglobin vesicle elevates tumor tissue oxygen tension and modifies tumor response to irradiation. J Surg Res 2009; 151: 48-54.
14. Sakai H, Sato A, Masuda K, Takeoka S, Tsuchida E,. Encapsulation of concentrated hemoglobin solution in phospholipid vesicles retards the reaction with NO, but not CO, by intracellular diffusion barrier. J Biol Chem 2008; 283: 1508-1517.
15. 2 release when perfused through narrow gas-permeable tubes. Am J Physiol Heart Circ Physiol 2010; 298: H956-H965.
16. 2 carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol 2000; 279: H908-H915.
17. Takeoka S, Ohgushi T, Terase K, Ohmori T, Tsuchida E,. Layer-controlled hemoglobin vesicles by interaction of hemoglobin with a phospholipid assembly. Langmuir 1996; 12: 1755-1759. (Pubitemid 126568169)
18. Izumi Y, Sakai H, Kose T, Hamada K, Takeoka S, Yoshizu A, Horinouchi H, Kato R, Nishide H, Tsuchida E, Kobayashi K,. Evaluation of the capabilities of a hemoglobin vesicle as an artificial oxygen carrier in a rat exchange transfusion model. ASAIO J 1997; 43: 289-297. (Pubitemid 27315122)
19. Abe H, Azuma H, Yamaguchi M, Fujihara M, Ikeda H, Sakai H, Takeoka S, Tsuchida E,. Effects of hemoglobin vesicles, a liposomal artificial oxygen carrier, on hematological responses, complement and anaphylactic reactions in rats. Artif Cells Blood Substit Immobil Biotechnol 2007; 35: 157-172. (Pubitemid 46514900)
20. Sou K, Tsuchida E,. Electrostatic interactions and complement activation on the surface of phospholipid vesicle containing acidic lipids: Effect of the structure of acidic groups. Biochim Biophys Acta 2008; 1778: 1035-1041.
21. Abe H, Fujihara M, Azuma H, Ikeda H, Ikebuchi K, Takeoka S, Tsuchida E, Harashima H,. Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma: Effects on coagulation, kallikrein-kinin, and complement systems. Artif Cells Blood Substit Immobil Biotechnol 2006; 34: 1-10. (Pubitemid 43127930)
22. Warner AE,. Pulmonary intravascular macrophages. Role in acute lung injury. Clin Chest Med 1996; 17: 125-135. (Pubitemid 26100798)
23. Brain JD, Molina RM, DeCamp MM, Warner AE,. Pulmonary intravascular macrophages: Their contribution to the mononuclear phagocyte system in 13 species. Am J Physiol Lung Cell Mol Physiol 1999; 276: L146-L154. (Pubitemid 29061676)
24. Garty I, Tal I, Kaynan A,. Tc-99 m colloid lung uptake in a rare case of toxoplasmosis with liver involvement. Clin Nucl Med 1984; 9: 310-313. (Pubitemid 14099364)
25. Sou K,. Electrostatics of carboxylated anionic vesicles for improving entrapment capacity. Chem Phys Lipids 2011; 164: 211-215.
26. Goins B, Phillips WT, Klipper R, Rudolph AS,. Role of complement in rats injected with liposome-encapsulated hemoglobin. J Surg Res 1997; 68: 99-105. (Pubitemid 27250947)
27. Loughrey HC, Bally MB, Reinish LW, Cullis PR,. The binding of phosphatidylglycerol liposomes to rat platelets is mediated by complement. Thromb Haemost 1990; 64: 172-176. (Pubitemid 20301873)
28. Tsuchida E, Sou K, Nakagawa A, Sakai H, Komatsu T, Kobayashi K,. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry. Bioconjug Chem 2009; 20: 1419-1440.
29. Pape A, Kertscho H, Meier J, Horn O, Laout M, Steche M, Lossen M, Theisen A, Zwissler B, Habler O,. Improved short-term survival with polyethylene glycol modified hemoglobin liposomes in critical normovolemic anemia. Intensive Care Med 2008; 34: 1534-1543.
30. Bradley AJ, Maurer-Spurej E, Brooks DE, Devine DV,. Unusual electrostatic effects on binding of C1q to anionic liposomes: Role of anionic phospholipid domains and their line tension. Biochemistry 1999; 38: 8112-8123.
31. Chang TM, Lister CW,. Assessment of blood substitutes: II. In-vitro complement activation of human plasma and blood for safety studies in research, development, industrial production and preclinical analysis. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 171-180. (Pubitemid 24202374)
32. Bradley AJ, Devine DV, Ansell SM, Janzen J, Brooks DE,. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. Arch Biochem Biophys 1998; 357: 185-194. (Pubitemid 28419200)
33. Winkler GC,. Pulmonary intravascular macrophages in domestic animal species: Review of structural and functional properties. Am J Anat 1988; 181: 217-234.
34. Albertine KH, Staub NC,. Vascular tracers alter hemodynamics and airway pressure in anesthetized sheep. Microvasc Res 1986; 32: 279-288. (Pubitemid 17213832)
35. Sakai H, Horinouchi H, Tomiyama K, Ikeda E, Takeoka S, Kobayashi K, Tsuchida E,. Hemoglobin-vesicles as oxygen carriers: Influence on phagocytic activity and histopathological changes in reticuloendothelial system. Am J Pathol 2001; 159: 1079-1088. (Pubitemid 32847198)
36. Sakai H, Masada Y, Horinouchi H, Ikeda E, Sou K, Takeoka S, Suematsu M, Takaori M, Kobayashi K, Tsuchida E,. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days. J Pharmacol Exp Ther 2004; 311: 874-884. (Pubitemid 39612691)
37. Longworth KE, Westgate AM, Grady MK, Westcott JY, Staub NC,. Development of pulmonary intravascular macrophage function in newborn lambs. J Appl Physiol 1992; 73: 2608-2615. (Pubitemid 23019678)
38. Miyamoto K, Schultz E, Heath T, Mitchell MD, Albertine KH, Staub NC,. Pulmonary intravascular macrophages and hemodynamic effects of liposomes in sheep. J Appl Physiol 1988; 64: 1143-1152. (Pubitemid 18088537)
39. Miyamoto K, Nakano T, Aoi K, Aida A, Kawakami Y,. Effects of differently composed liposomes on pulmonary arterial pressure in sheep-involvement of pulmonary intravascular macrophages. Nihon Kyobu Shikkan Gakkai Zasshi 1991; 29: 1268-1274.
40. Wassef NM, Johnson SH, Graeber GM, Swartz GM Jr, Schultz CL, Hailey JR, Johnson AJ, Taylor DG, Ridgway RL, Alving CR,. Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs. J Immunol 1989; 143: 2990-2995. (Pubitemid 19281849)
41. Sakai H, Hisamoto S, Fukutomi I, Sou K, Takeoka S, Tsuchida E,. Detection of lipopolysaccharide in hemoglobin-vesicles by Limulus amebocyte lysate test with kinetic-turbidimetric gel clotting analysis and pretreatment of surfactant. J Pharm Sci 2004; 93: 310-321. (Pubitemid 38174254)
42. Szebeni J, Wassef NM, Rudolph AS, Alving CR,. Complement activation by liposome-encapsulated hemoglobin in vitro: The role of endotoxin contamination. Artif Cells Blood Substit Immobil Biotechnol 1995; 23: 355-363.
43. Zeltner TB, Caduff JH, Gehr P, Pfenninger J, Burri PH,. The postnatal development and growth of the human lung. I. Morphometry. Respir Physiol 1987; 67: 247-267. (Pubitemid 17040316)
44. Taguchi K, Miyasato M, Ujihira H, Watanabe H, Kadowaki D, Sakai H, Tsuchida E, Horinouchi H, Kobayashi K, Maruyama T, Otagiri M,. Hepatically metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment. Toxicol Appl Pharmacol 2010; 248: 234-241.